Salesforce Is Betting on the Era of the Agentic Enterprise. Is the Stock a Buy Now?

Source The Motley Fool

Key Points

  • A new long-term plan points to at least $60 billion in revenue by fiscal 2030.

  • Early traction in artificial intelligence (AI) agents suggests Salesforce's broad platform is paying off.

  • The valuation is high but looks fair today, with upside riding on faster organic growth.

  • 10 stocks we like better than Salesforce ›

Shares of Salesforce (NYSE: CRM) moved higher this week after management used its annual Dreamforce conference to reset long-term expectations. The customer relationship management (CRM) specialist now targets at least $60 billion of revenue by fiscal 2030, excluding any contributions from its recent acquisition of Informatica. In addition, the company introduced a profitability yardstick that pairs growth and margins.

The broader theme in Salesforce's upbeat outlook is the agentic enterprise, where AI (artificial intelligence) agents handle work across sales, service, marketing, and data.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks »

Salesforce is best known for CRM software, but its platform spans marketing automation, analytics, integration, collaboration, and data management. That breadth matters for AI because unified data and workflows make it easier to deploy agents that do real tasks. This helps explain why the company is seeing explosive growth in its data and AI offering, and why Salesforce expects enterprise adoption of agentic tools to help the company maintain double-digit organic revenue growth through the end of fiscal 2030.

Salesforce logo.

Image source: Salesforce.

Big targets

Salesforce aims for at least $60 billion of revenue by fiscal 2030, which implies a 10% or higher organic compound growth rate between fiscal 2026 and fiscal 2030. Management also introduced a target it is calling "50 by FY30," in which the company expects the sum of its subscription and support constant-currency revenue growth rate and non-GAAP (generally accepted accounting principles) operating margin to equal 50 by the end of fiscal 2030.

To help investors have confidence in Salesforce's ambitious expectations, management noted that its data and AI annual recurring revenue (ARR) reached about $1.2 billion in the second quarter and grew about 120% year over year. Management also disclosed about $440 million in agentic AI ARR and stated that more than 12,000 customers have already adopted Agentforce.

"We're leading the next great transformation in business -- the era of the Agentic Enterprise," CEO Marc Benioff said in a press release about the targets it disclosed at its Investor Day event at Dreamforce, calling Agentforce the company's "fastest-growing organic product ever."

Salesforce chief financial and operating officer Robin Washington said its Agentforce platform was built as a result of more than $10 billion of focused research and development since the start of fiscal 2024.

Building on strong momentum

In the meantime, Salesforce is already putting up good numbers. Revenue in its fiscal second quarter rose 10% year over year to about $10.2 billion, and subscription and support revenue grew 11%. Current remaining performance obligations (future revenue under contract expected to be recognized as revenue in the next 12 months) increased 11%.

Notably, the company also raised its full-year revenue guidance to between $41.1 billion and $41.3 billion (8% to 9% growth). Additionally, it raised its guidance for non-GAAP operating margin to 34.1%.

But is the stock too expensive? Trading at 36 times earnings as of this writing, shares certainly aren't cheap. But the valuation isn't extreme for a software platform with a non-GAAP operating margin in the mid-thirties and clear levers to lift growth as AI adoption broadens.

Salesforce's success depends on continued rapid customer adoption of AI agents while protecting its margins -- even as the company continues to invest aggressively in the technology needed to grow this business. Additionally, investors should keep an eye on the macroeconomic environment and how it impacts adoption. An uncertain environment could stretch sales cycles and slow customer expansion within the Salesforce ecosystem of software and services. Finally, the "50 by FY30" yardstick is simple and trackable (which is helpful), but it also raises the bar and ultimately will make any slippage obvious.

Ultimately, the stock looks interesting at its current price, but isn't a clear buy -- not because the company doesn't have a lot going for it, but because of its premium valuation. Still, for investors seeking exposure to enterprise AI, a very small position could make sense. Investors could always add to the position on any pullbacks in the stock, assuming the company is executing well.

Should you invest $1,000 in Salesforce right now?

Before you buy stock in Salesforce, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Salesforce wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $638,300!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,114,470!*

Now, it’s worth noting Stock Advisor’s total average return is 1,044% — a market-crushing outperformance compared to 188% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.

See the 10 stocks »

*Stock Advisor returns as of October 13, 2025

Daniel Sparks and his clients have no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Salesforce. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Lilly, Novo Nordisk Shares Plummet as Trump Announces Price Cut to OzempicOn Thursday, shares of Eli Lilly and Novo Nordisk fell sharply in after-hours trading after President Donald Trump announced a significant price reduction for the diabetes drug Ozempic.
Author  TradingKey
Yesterday 09: 16
On Thursday, shares of Eli Lilly and Novo Nordisk fell sharply in after-hours trading after President Donald Trump announced a significant price reduction for the diabetes drug Ozempic.
placeholder
WTI slumps to near $56.50 as Trump and Putin summit loomsWest Texas Intermediate (WTI), the US crude oil benchmark, is trading around $56.50 during the early European trading hours on Friday.
Author  FXStreet
Yesterday 09: 12
West Texas Intermediate (WTI), the US crude oil benchmark, is trading around $56.50 during the early European trading hours on Friday.
placeholder
Are European Stocks Peaking? SocGen,Citi Turn Bearish on Q4, U.S. Regional Bank Crisis Adds New RiskA series of bad loan incidents in the U.S. are catalyzing a credit crisis in the banking sector, and these concerns are now spreading to Europe’s top-performing bank stocks this year.
Author  TradingKey
Yesterday 09: 07
A series of bad loan incidents in the U.S. are catalyzing a credit crisis in the banking sector, and these concerns are now spreading to Europe’s top-performing bank stocks this year.
placeholder
Gold-backed PAXG hits record volumes, trades at premium to spotPAXG traded at a premium on Binance, based on an anomalous price spike above $5,000, which liquidated short positions.
Author  Cryptopolitan
Yesterday 09: 00
PAXG traded at a premium on Binance, based on an anomalous price spike above $5,000, which liquidated short positions.
placeholder
Meme Coins Price Prediction: Dogecoin, Shiba Inu, Pepe flash bearish potential Meme coins such as Dogecoin (DOGE), Shiba Inu (SHIB), and Pepe (PEPE) are at risk of steeper corrections as the broader cryptocurrency market weakens.
Author  FXStreet
Yesterday 08: 57
Meme coins such as Dogecoin (DOGE), Shiba Inu (SHIB), and Pepe (PEPE) are at risk of steeper corrections as the broader cryptocurrency market weakens.
goTop
quote